China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.53415
+0.0041 (0.78%)
At close: May 11, 2026, 4:00 PM EDT
0.53415
0.00 (0.00%)
After-hours: May 11, 2026, 4:10 PM EDT

China Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
221986723
Market Cap Growth
300.83%147.12%18.23%-10.61%-68.52%12.44%
Enterprise Value
25.8319.989.498.4611.4225.97
Last Close Price
0.531.212.336.0548.00241.30
PE Ratio
--1.64-0.86-0.66-1.27-6.52
PS Ratio
5.384.531.680.920.892.37
PB Ratio
0.360.830.980.861.683.80
P/TBV Ratio
0.100.230.530.281.183.70
P/FCF Ratio
250.59211.18-17.10-9.04-8.86-33.21
P/OCF Ratio
150.32126.68-18.72-9.19-17.56-91.44
EV/Sales Ratio
6.234.822.101.211.412.69
EV/EBITDA Ratio
--12.04-4.964617.81-13.46114.25
EV/EBIT Ratio
--6.17-2.07-3.08-3.22-9.08
EV/FCF Ratio
290.42224.69-21.35-11.90-14.08-37.75
Debt / Equity Ratio
0.070.070.330.471.461.34
Debt / EBITDA Ratio
-2.07-2.17-1.882528.11-10.3254.94
Debt / FCF Ratio
40.4340.43-8.08-6.52-10.79-18.15
Net Debt / Equity Ratio
0.140.140.380.421.571.25
Net Debt / EBITDA Ratio
-1.87-1.96-1.541715.36-7.9133.16
Net Debt / FCF Ratio
36.5536.55-6.63-4.42-8.27-10.96
Asset Turnover
0.180.180.290.410.400.44
Inventory Turnover
2.202.202.172.182.732.64
Quick Ratio
0.090.090.180.320.200.54
Current Ratio
0.320.320.650.880.470.86
Return on Equity (ROE)
-20.91%-20.91%-62.31%-52.43%-77.08%-48.49%
Return on Assets (ROA)
-14.12%-14.12%-29.27%-16.07%-17.55%-13.07%
Return on Invested Capital (ROIC)
-15.00%-15.00%-33.39%-19.39%-22.79%-16.27%
Return on Capital Employed (ROCE)
-19.36%-19.36%-47.02%-37.46%-41.31%-26.18%
Earnings Yield
-14.30%-61.16%-116.31%-150.41%-78.75%-15.33%
FCF Yield
0.40%0.47%-5.85%-11.06%-11.28%-3.01%
Buyback Yield / Dilution
-145.73%-145.73%-416.13%-221.82%-13.96%-5.74%
Total Shareholder Return
-145.73%-145.73%-416.13%-221.82%-13.96%-5.74%
Updated Apr 1, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q